• No results found

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

N/A
N/A
Protected

Academic year: 2022

Share "Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness"

Copied!
23
0
0

Loading.... (view fulltext now)

Full text

(1)

Barriers to Healthcare Services for People with Mental Disorders

Cardiovascular disorders and diabetes in people with severe mental illness

Dr. med. J. Cordes

LVR- Klinikum Düsseldorf

Kliniken der Heinrich-Heine-Universität Düsseldorf Bergische Landstr. 2, D-40629 Düsseldorf

(2)

Epidemiology

Cardiovascular disorders and diabetes in people with severe mental illness

Mortality and morbidity of depression

Prevalence of the metabolic syndrome in patients with severe mental illness

Pathophysiologic data

Risk factors for the development of metabolic syndrome

Barriers to Healthcare Services

Challenges

Monitoring

Psychoeducation and psychotherapy

Consequences

(3)

Excess mortality in bipolar and unipolar disorder.

All patients with a hospital diagnosis of bipolar (n = 15 386) or unipolar (n = 39 182) disorder in Sweden from 1973 to 1995 were linked with the national cause-of-death register.

Ösby U et al. Arch Gen Psychiatry 2001; 58: 844-850

Standardized Mortality ratios

Cause of death cardiovascular

Cause of death cerebrovascular

Female Unipolar Bipolar

1.7 2.6

1.5 2.0 Male

Unipolar Bipolar

1.5 1.9

1.5

1.9

(4)

The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease

single past major depressive episode (29%) current dysthymic disorder (15%)

recurrent major depressive disorder

with current major depressive episode (31%) current alcohol abuse (19%)

posttraumatic stress disorder (29%)

current generalized anxiety disorder (24%) current binge-eating disorder (10%)

current primary insomnia (13%).

The mean number of comorbid clinical psychiatric disorders per subject was 1.7.

Bankier et al., Psychosom. Med. 2004; 66: 645-650

(5)

all-cause mortality OR 2.38 studies before 1992

studies after 1992

cardiac mortality OR 2.59 cardiovascular events

Van Melle et al., Psychosom. Med. 2004; 66: 814-822

1 2 3 4 5 -5 -4 -3 -2 -1

Prognostic association of depression following myocardial infarction with mortality and

cardiovascular events: a meta-analysis.

(6)

Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after

myocardial infarction, N=896

Lesperance F et al. Circulation 2002; 105: 1049-1053

(7)

HR (Cox) 95% CI All-causes mortality

Depression 1.20 1.03-1.40

Diabetes 1.88 1.55-2.27

Diabetes+Depression 2.50 2.04-3.08

CHD-mortality

Depression 1.29 0.96-1.74

Diabetes 2.26 1.60-3,21

Diabetes+Depression 2.43 1.66-3.56

Depression and all-cause and coronary heart disease mortality among adults with and without diabetes.

Egede ,Diabetes Care 2005;28:1339-45

NHANES I; n = 10025; 8 years follow-up

(8)

risc factors range

viscerale obesity circumference: M:>102 cm; F:>88 cm

diabetes fasting BG: 110 mg/dl

hypertonia 130/85 mm Hg

increased triglyceride 150 mg/dl

decreased HDL cholesterol m:<40 mg/dl; f:<50 mg/dl

Definition of the Metabolic Syndrome

3 von 5 criteria

NCEP

(9)

Hea lthy

subj ects

Schizop hren

ia

Dep res

sion

Bipolar

Addi ction 0

25 50

Prevalence MetS (%)

Kahl et al., under review

Increased prevalence of the metabolic syndrome in patients with severe mental illness

Age BMI

Healthy

Schizophrenia 39,3±13,2 25,1±3,8

Depression 42,7±14,0 26,2±6,0

Bipolar 47,7±15,3 25,5±5,1

Addiction 46,5±11,0 25,5±5,3

(10)

Metabolisches Syndrom Cytokines and adipokines

HPAS and cortisol

Alcohol Smoking

Lifestyle, Compliance

Poorness,

Barriers to healthcare services

Unmodifiable RF Age

Gender

Ethnic factors

drugs Metabolisches

Syndrom Metabolic

syndrom

Risk factors for the development of the metabolic syndrome

Low birth weight

(11)

Weight gain and Antipsychotics

drug weight diabetes lipids

gain

Clozapine +++ + +

Olanzapine +++ + +

Risperidone ++ D D

Quetiapine ++ D D

Aripiprazol* +/- - -

Ziprasidon* +/- - -

+ = increased; - = no effect; D = unclear

*new drugs with limited data of longterm treatment

Consensus Statement: ADA, APA, AACE, NAASO, Diabetes Care 2004; 27: 596-601

(12)

depression in West Germany:

4 Mio

60-70%

general practitioner 2,4 - 2,8 Mio.

30-35%

precise diagnosed 1,2 - 1,4 Mio.

10%

appropriate therapy 400.000

Diagnostic and therapeutic Deficit

(13)

Wong, C.-K. et al. QJM 2008 101:137-144

Pre-existent depression in the 2 weeks before acute coronary syndrome can be associated with delayed presentation of the

heart attack. (N=276)

(14)

Social support, depression during the first week after myocardial infarction and mortality during the first year

after myocardial infarction (N=887).

Frasure-Smith N et al. Circulation 2000; 101: 1919-1924

(15)

Barriers to Healthcare Services

Negative attitudes towards somatic treatment

Negative attitudes towards psychiatric patients

Insufficient health care compensation systems

Insufficient healthcare supplies of somatic illness in psychiatric patients.

Structurally inadequate level of internal

medicine in psychiatric hospitals and

ambulances

(16)

Monitoring Protocol for Patients on Second-Generation Antipsychotics

X X

X

fasting lipid profile

X X

waist

circumference

X X

X

fasting plasma glucose

X X

X

blood pressure

X X

X X

weight (BMI) X

X X

personal / family history

every 5 years annually

quarterly 12 weeks

8 weeks 4 weeks

baseline

Consensus Statement: ADA, APA, AACE, NAASO, Diabetes Care 2004; 27: 596-601

(17)

Intervention Programs

Reducing weight can positively influence many components of metabolic syndrome

Clinical guidelines exist

Evidence of effectiveness of behavioral- therapeutic programs

Methods:

Nutritional therapy

Physical exercise programs

Behavioral therapy

Emotional / moral support is another

factor

(18)

Our Study Hypothesis

A 24-week psychoeducational

weight-management program can decrease weight gain in

schizophrenic patients taking olanzapine

Cordes J, Thünker J, Klimke A, Hauner H

(19)

Study Procedure

t

screening intervention follow-up

(20)

Methods

100 schizophrenic patients

Sham group (N=39)

• mean age = 36.05

• male = 27

• 1 superficial briefing

Verum group (N=35)

• mean age = 37.97

• male = 15

• 12 sessions of in-depth weight- management training

(21)

60 65 70 75 80 85 90 95

0 1 2 4 8 12 24 36 48

Week

Weight in kg Men, control

Women, control Men, prevention Woman, prevention

Figure 2:

Development of the mean body weight over time. N = 27, 11, 15, and 21.

(22)

Development of the glucose level two hours after dextrose administration

(N = 27, 10, 15, 18)

80 90 100 110 120 130 140

0 1 2

Glucose level two hours after glucose administration in mg/dl

Men, control Women, control Men, prevention Woman, prevention

(23)

There is a need for sufficient provision of medical health care service for severe mentally illnesses

We need an interdisciplinary concept including case management and sufficient health care compensation systems

The psychiatric knowledge of the physician and the

somatic medicine knowledge of the psychiatrist should be improved

We need early interventions and a regular monitoring to prevent cardiovascular risk

More research to identify relevant barriers is needed

Conclusion

References

Related documents

A maximum error estimate of less than ±10% was found, in the overall computed longitudinal aerodynamic characteristics at wind tunnel Reynolds numbers, between the base and

[r]

Consequently, the maximum score of each maturity dimension will be equal to 40 (8*5=40) Similarly the mature and immature portfolios and their maturity levels from the aspect

 People with severe mental illness are at higher risk of some physical health problems, such as diabetes, heart disease, obesity and stroke..  People with severe mental illness

All Rights Reserved Used by Permission of the Copyright Owner.. Morris

At the end of 1 year, the placebo- treated patients had regained 56% of their body weight, compared with 32.4% in the group treated with orlistat at 120 mg three times a day.. The

The Lower Cambrian, Middle and Upper Devo- nian, Lower Carboniferous (carbonate and clas- tic) strata were analyzed from the Upper Silesian Block Palaeozoic profile and the Middle

Wi-Fi and Enterprise Small Cells Provide Cost-Effective Indoor Network Expansion. •   Small Cells and Wi-Fi